CARE-HF trial demonstrated that Gal-3 was an independent predictor of death from any cause or unplanned hospitalization for a major cardiovascular event; however, Gal-3 did not predict CRT response when considered as a separate outcome. This evidence concerns the gene LGALS3 and hydrops fetalis.